Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet TOPAMAX 25mg film-coated tablets
- Product code:
- W58597007
- Quantity:
- 60
- Indicated for:
- epilepsy; migraine prevention
- Route of administration:
- oral
- Substance:
- topiramate (antiepileptic)
- ATC
- N03AX11 — Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Contraception required
Effective contraception is required during treatment.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Suicidal ideation / mental changes
Seek medical help if suicidal thoughts or major behavior changes occur.
Teratogenic / fetal risk
This medicine may affect fetal development.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Vision disturbances
This medicine may cause vision disturbances.
Topiramate is an antiepileptic drug used in the treatment of epilepsy and migraines. It works through multiple mechanisms, including blocking sodium channels, enhancing GABA (gamma-aminobutyric acid) activity, and inhibiting glutamate receptors, thereby reducing neuronal excitability.
Topiramate is administered orally, usually twice daily, with the dose gradually adjusted to minimize the risk of side effects. It is indicated both as monotherapy and as adjunctive therapy in controlling seizures and preventing migraines.
Common side effects include drowsiness, dizziness, weight loss, memory disturbances, and tingling sensations in the extremities. In rare cases, severe adverse reactions such as metabolic acidosis, glaucoma, or kidney stone formation may occur. Regular monitoring of the patient's condition is essential during treatment.
Topiramate is an effective and well-tolerated therapeutic option for managing epilepsy and migraines, contributing to improved quality of life for patients.
Topiramate is administered orally, usually twice daily, with the dose gradually adjusted to minimize the risk of side effects. It is indicated both as monotherapy and as adjunctive therapy in controlling seizures and preventing migraines.
Common side effects include drowsiness, dizziness, weight loss, memory disturbances, and tingling sensations in the extremities. In rare cases, severe adverse reactions such as metabolic acidosis, glaucoma, or kidney stone formation may occur. Regular monitoring of the patient's condition is essential during treatment.
Topiramate is an effective and well-tolerated therapeutic option for managing epilepsy and migraines, contributing to improved quality of life for patients.
General data about TOPAMAX 25mg
- Substance:
- topiramate
- Date of latest medicines list:
- 01-12-2019
- Product code:
- W58597007
- Concentration:
- 25mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 60
- Product type:
- Original
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for topiramate
Concentrations available for topiramate
- 100mg
- 15mg
- 200mg
- 25mg
- 400mg
- 50mg